BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 5423363)

  • 1. Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1970 Apr; 23(4):184-94. PubMed ID: 5423363
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefazolin, a new semisynthetic cephalosporin antibiotic. VI. Excretion and metabolism of cefazolin- 14 C in rats after intramuscular administration.
    Kozatani J; Okui M; Matsubara T; Nishida M
    J Antibiot (Tokyo); 1972 Feb; 25(2):86-93. PubMed ID: 5034810
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C; Gordon RC; Kirby WM
    Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on new antibiotic lividomycins. VI. Absorption, excretion and tissue distribution of lividomycin A.
    Mori T; Aoki M; Aoki Y; Shirai K; Chiba K
    J Antibiot (Tokyo); 1972 Nov; 25(11):634-40. PubMed ID: 4647833
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftezole, a new cephalosporin C derivative II. Distribution and excretion in parenteral administration.
    Harada Y; Matsubara S; Kakimoto M; Noto T; Nehashi T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1071-82. PubMed ID: 994326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the distribution of semisynthetic cephalosporins in the body of rats].
    Iakovlev VP; Klimova VS; Rudzit EA
    Antibiotiki; 1979 Feb; 24(2):109-14. PubMed ID: 434800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution and excretion of SCE-963, a new broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
    Tsuchiya K; Kondo M; Kita Y; Noji Y; Takeuchi M; Fugono T
    J Antibiot (Tokyo); 1978 Dec; 31(12):1272-82. PubMed ID: 738967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration.
    Tuano SB; Brodie JL; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1966; 6():101-6. PubMed ID: 5985234
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on chemotherapy during the perinatal period with special reference to such derivatives of cephalosporin C as cefazolin, cephaloridine and cephalothin.
    Fukada M
    Jpn J Antibiot; 1973 Jun; 26(3):197-214. PubMed ID: 4542543
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.
    Rylander M; Holm SE; Norrby R; Brorson JE
    Scand J Infect Dis Suppl; 1978; (13):52-7. PubMed ID: 278147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the interaction of cephalosporins with blood serum proteins and organ homogenates].
    Klimova VS; Iakovlev VP
    Antibiotiki; 1979 Nov; 24(11):835-8. PubMed ID: 507778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, tissue concentration, and organ distribution of cefazolin.
    Ishiyama S; Nakayama I; Iwamoto H; Iwai S; Okui M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():476-80. PubMed ID: 5521371
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cephazolin: pharmacology compared with that of 2 other cephalosporins].
    Guibert J; Lavarde M; Goldstein F
    Nouv Presse Med; 1974 Apr; 3(0):19-20. PubMed ID: 4837110
    [No Abstract]   [Full Text] [Related]  

  • 15. [Absorption and excretion of cephapirin (author's transl)].
    Morikawa A; Maruta H; Mizuno D
    Jpn J Antibiot; 1974 Apr; 27(2):182-4. PubMed ID: 4546584
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of cephalosporin antibiotics: protein-binding considerations.
    Singhvi SM; Heald AF; Schreiber EC
    Chemotherapy; 1978; 24(3):121-33. PubMed ID: 657874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the metabolism of cephalosporins. I. The distribution and degradation of 7-[(1-14C)-3-chlorophenyl-acetamido]-cephalosporanic acid.
    Okui M; Hattori K; Nishida M
    J Antibiot (Tokyo); 1967 Sep; 20(5):287-92. PubMed ID: 5630772
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood distribution, renal and biliary excretion of a new caphalosporin, cephacetrile (Ciba 36278 Ba)].
    Brogard JM; Kuntzmann F; Lavillaureix J
    Schweiz Med Wochenschr; 1973 Jan; 103(3):110-4. PubMed ID: 4566986
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefoperazone: absorption, excretion, distribution, and metabolism.
    Shimizu K
    Clin Ther; 1980; 3(Spec Issue):60-79. PubMed ID: 6446400
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.
    Regamey C; Libke RD; Clarke JT; Kirby WM
    Infection; 1974; 2(3):132-6. PubMed ID: 4415038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.